News Only 3 in 20 new drugs approved in Germany in 2011 were an improvement, report says BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2657 (Published 08 April 2014) Cite this as: BMJ 2014;348:g2657 Article Related content Metrics Responses Peer review Related articles News Measures to cut Germany’s drugs bill start to take effect Published: 19 September 2011; BMJ 343 doi:10.1136/bmj.d5999 News Manufacturers urge German government to revise proposals for pricing new drugs Published: 13 June 2012; BMJ 344 doi:10.1136/bmj.e4069 News German drug companies are criticised for not focusing on useful therapeutic areas Published: 15 September 2015; BMJ 351 doi:10.1136/bmj.h4938 See more Communicating risk to patients in the emergency department BMJ December 05, 2016, 355 i6437; DOI: https://doi.org/10.1136/bmj.i6437 Biological treatment is approved for severe eosinophilic asthma BMJ December 01, 2016, 355 i6472; DOI: https://doi.org/10.1136/bmj.i6472 Patient care is at risk from lack of new funds in autumn statement, healthcare leaders warn BMJ November 24, 2016, 355 i6356; DOI: https://doi.org/10.1136/bmj.i6356 Government must be clearer in its claims about NHS funding, says statistics watchdog BMJ November 24, 2016, 355 i6340; DOI: https://doi.org/10.1136/bmj.i6340 US must address addiction as an illness, not as a moral failing, Surgeon General says BMJ November 22, 2016, 355 i6265; DOI: https://doi.org/10.1136/bmj.i6265 Cited by... Drugs and Devices: Comparison of European and U.S. Approval ProcessesAbstract Fulltext PDF German drug companies are criticised for not focusing on useful therapeutic areasAbstract Fulltext PDF
